Application Sponsors
ANDA 071717 | AUROLIFE PHARMA LLC | |
Marketing Status
Discontinued | 001 |
Discontinued | 002 |
Application Products
001 | CAPSULE;ORAL | 30MG | 0 | FLURAZEPAM HYDROCHLORIDE | FLURAZEPAM HYDROCHLORIDE |
002 | CAPSULE;ORAL | 15MG | 0 | FLURAZEPAM HYDROCHLORIDE | FLURAZEPAM HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 1991-07-31 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 1994-01-24 | |
LABELING; Labeling | SUPPL | 4 | AP | 2016-12-16 | STANDARD |
Submissions Property Types
CDER Filings
AUROLIFE PHARMA LLC
cder:Array
(
[0] => Array
(
[ApplNo] => 71717
[companyName] => AUROLIFE PHARMA LLC
[docInserts] => ["",""]
[products] => [{"drugName":"FLURAZEPAM HYDROCHLORIDE","activeIngredients":"FLURAZEPAM HYDROCHLORIDE","strength":"30MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"FLURAZEPAM HYDROCHLORIDE","activeIngredients":"FLURAZEPAM HYDROCHLORIDE","strength":"15MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"FLURAZEPAM HYDROCHLORIDE","submission":"FLURAZEPAM HYDROCHLORIDE","actionType":"30MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"FLURAZEPAM HYDROCHLORIDE","submission":"FLURAZEPAM HYDROCHLORIDE","actionType":"15MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)